Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Julia D. S. Hanauer"'
Autor:
Dina Kleinlützum, Julia D. S. Hanauer, Alexander Muik, Kay-Martin Hanschmann, Sarah-Katharina Kays, Camilo Ayala-Breton, Kah-Whye Peng, Michael D. Mühlebach, Tobias Abel, Christian J. Buchholz
Publikováno v:
Frontiers in Oncology, Vol 7 (2017)
Therapy resistance and tumor recurrence are often linked to a small refractory and highly tumorigenic subpopulation of neoplastic cells, known as cancer stem cells (CSCs). A putative marker of CSCs is CD133 (prominin-1). We have previously described
Externí odkaz:
https://doaj.org/article/d47923f70d0840cbafc22bc9a072b932
Autor:
Julia D. S. Hanauer, Shiwani Agarwal, Annika M. Frank, Frederic B. Thalheimer, Vanessa Riechert, Christian J. Buchholz
Publikováno v:
Molecular Therapy. 28:1783-1794
T cells modified with CD19-specific chimeric antigen receptors (CARs) result in significant clinical benefit for leukemia patients but constitute a challenge for manufacturing. We have recently demonstrated the in vivo generation of CD19-CAR T cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::613bf83411a3dacbf5aa08bea430465f
https://doi.org/10.1016/j.ymthe.2020.05.005
https://doi.org/10.1016/j.ymthe.2020.05.005
Autor:
Shiwani, Agarwal, Julia D S, Hanauer, Annika M, Frank, Vanessa, Riechert, Frederic B, Thalheimer, Christian J, Buchholz
Publikováno v:
Mol Ther
T cells modified with CD19-specific chimeric antigen receptors (CARs) result in significant clinical benefit for leukemia patients but constitute a challenge for manufacturing. We have recently demonstrated the in vivo generation of CD19-CAR T cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::03f20714bc2e9d576691a59d90af3fdf
https://pubmed.ncbi.nlm.nih.gov/32485137
https://pubmed.ncbi.nlm.nih.gov/32485137
Autor:
Alexander Muik, Julia D. S. Hanauer, Dina Kleinluetzum, Kah-Whye Peng, Camilo Ayala-Breton, Christian J. Buchholz, Sarah-Katharina Kays
Publikováno v:
Molecular Therapy. 24:S259
Therapy resistance and tumor recurrence are often linked to cancer stem cells (CSCs) which represent a minor proportion of highly refractory cancer-propagating cells within a tumor. A putative marker of CSCs is CD133 (prominin-1) which has been sugge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abd786dd2c91d0783c5f5f8be09a9a03
https://doi.org/10.1016/s1525-0016(16)33462-1
https://doi.org/10.1016/s1525-0016(16)33462-1